000 | 01910 a2200517 4500 | ||
---|---|---|---|
005 | 20250517052811.0 | ||
264 | 0 | _c20170515 | |
008 | 201705s 0 0 eng d | ||
022 | _a1097-6809 | ||
024 | 7 |
_a10.1016/j.jvs.2015.06.140 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEdwards, Bryan B | |
245 | 0 | 0 |
_aBiochemically engineered stromal cell-derived factor 1-alpha analog increases perfusion in the ischemic hind limb. _h[electronic resource] |
260 |
_bJournal of vascular surgery _c10 2016 |
||
300 |
_a1093-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 |
_aAngiogenesis Inducing Agents _xadministration & dosage |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBlood Flow Velocity |
650 | 0 | 4 |
_aChemokine CXCL12 _xadministration & dosage |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xpharmacology |
650 | 0 | 4 | _aHindlimb |
650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
650 | 0 | 4 | _aInjections, Intramuscular |
650 | 0 | 4 |
_aIschemia _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
650 | 0 | 4 | _aProtein Engineering |
650 | 0 | 4 |
_aQuadriceps Muscle _xblood supply |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
650 | 0 | 4 | _aRecovery of Function |
650 | 0 | 4 | _aRegional Blood Flow |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xgenetics |
700 | 1 | _aFairman, Alexander S | |
700 | 1 | _aCohen, Jeffrey E | |
700 | 1 | _aMacArthur, John W | |
700 | 1 | _aGoldstone, Andrew B | |
700 | 1 | _aWoo, Jeffrey B | |
700 | 1 | _aHiesinger, William | |
700 | 1 | _aWoo, Y Joseph | |
773 | 0 |
_tJournal of vascular surgery _gvol. 64 _gno. 4 _gp. 1093-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jvs.2015.06.140 _zAvailable from publisher's website |
999 |
_c25263476 _d25263476 |